,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2020-10-21 10:30:01,"Chicago, IL – October 21, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog.",0.020210636779665947,0.012291818857192993,0.9674975275993347,neutral,0.007918817922472954
1,2020-10-21 10:30:01,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2020-10-21 10:30:01,"Stocks recently featured in the blog include: NVIDIA Corporation NVDA, salesforce.com, inc. CRM, AstraZeneca PLC AZN, JPMorgan Chase & Co. JPM and Chevron Corporation CVX.",0.018263036385178566,0.011228114366531372,0.970508873462677,neutral,0.007034922018647194
3,2020-10-21 10:30:01,"Here are highlights from Tuesday’s Analyst Blog:

The Zacks Research Daily presents the best research output of our analyst team.",0.24440903961658478,0.009972421452403069,0.7456185221672058,neutral,0.23443661630153656
4,2020-10-21 10:30:01,"Today's Research Daily features new research reports on 16 major stocks, including NVIDIA, salesforce.com and AstraZeneca.",0.04014677181839943,0.009177526459097862,0.9506756663322449,neutral,0.030969245359301567
5,2020-10-21 10:30:01,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
6,2020-10-21 10:30:01,"You can see all of today’s research reports here >>>

NVIDIA shares have outperformed the Zacks General Semiconductor industry in the year to date period (+132% vs. +35.8%) on the back of a demand boost from the coronavirus-induced work-from-home and learn-at-home wave.",0.9346486330032349,0.02072804421186447,0.044623374938964844,positive,0.9139205813407898
7,2020-10-21 10:30:01,"It is also benefiting from strong growth in GeForce desktop and notebook GPUs, which is boosting gaming revenues.",0.9498443007469177,0.017772294580936432,0.03238338604569435,positive,0.9320719838142395
8,2020-10-21 10:30:01,"Moreover, a surge in Hyperscale demand remains a tailwind for the company’s Data Center business.",0.06265778094530106,0.8982180953025818,0.03912416100502014,negative,-0.8355603218078613
9,2020-10-21 10:30:01,Expansion of NVIDIA GeForce NOW is expected to drive the user base.,0.8118150234222412,0.012769564986228943,0.17541545629501343,positive,0.7990454435348511
10,2020-10-21 10:30:01,"Further, solid uptake of AI-based smart cockpit infotainment solutions is a boon.",0.9077700972557068,0.03713960573077202,0.05509035661816597,positive,0.8706305027008057
11,2020-10-21 10:30:01,"Additionally, collaboration with Daimler-owned Mercedes-Benz is expected to further strengthen NVIDIA’s presence in the autonomous vehicles and other automotive electronics space.",0.9478034377098083,0.015580490231513977,0.03661613538861275,positive,0.9322229623794556
12,2020-10-21 10:30:01,"However, management expects COVID-19 pandemic to negatively impact near-term revenues by $100 million.",0.01782803051173687,0.9522273540496826,0.0299446452409029,negative,-0.9343993067741394
13,2020-10-21 10:30:01,"Moreover, the U.S.-China trade war remains a key concern.",0.07101248949766159,0.33921992778778076,0.589767575263977,neutral,-0.2682074308395386
14,2020-10-21 10:30:01,Shares of salesforce have gained +77.7% over the past year against the Zacks Computer Software industry’s rise of +47.1%.,0.9572769999504089,0.025368526577949524,0.017354458570480347,positive,0.9319084882736206
15,2020-10-21 10:30:01,The Zacks analyst believes that Salesforce is benefiting from a robust demand environment as customers are undergoing a major digital transformation.,0.9370110034942627,0.012953510507941246,0.05003540962934494,positive,0.9240574836730957
16,2020-10-21 10:30:01,The rapid adoption of its cloud-based solutions is driving demand for its products.,0.8499467372894287,0.01274961419403553,0.1373036950826645,positive,0.8371971249580383
17,2020-10-21 10:30:01,Salesforce’s sustained focus on introducing more aligned products as per customer needs is driving its top-line.,0.8445386290550232,0.012239380739629269,0.14322197437286377,positive,0.8322992324829102
18,2020-10-21 10:30:01,Continued deal wins in the international market is another growth driver.,0.9418046474456787,0.015575875528156757,0.04261942207813263,positive,0.9262287616729736
19,2020-10-21 10:30:01,"Furthermore, the recent acquisition of Tableau positions the company to be a leader in business analytics for actionable results in everything from operations to HR.",0.903748095035553,0.01346648670732975,0.08278544992208481,positive,0.890281617641449
20,2020-10-21 10:30:01,"However, stiff competition from Oracle and Microsoft is a concern.",0.05802709981799126,0.6175630688667297,0.3244097828865051,negative,-0.5595359802246094
21,2020-10-21 10:30:01,"Besides, unfavorable currency fluctuations along with increasing investments in international expansions and data centers are an overhang on near-term profitability.",0.1565628945827484,0.7921656370162964,0.05127149075269699,negative,-0.6356027126312256
22,2020-10-21 10:30:01,AstraZeneca’s shares have gained +5.1% over the past six months against the Zacks Large Cap Pharmaceuticals industry’s rise of +0.4%.,0.9573854207992554,0.025083370506763458,0.017531245946884155,positive,0.9323020577430725
23,2020-10-21 10:30:01,The Zacks analyst believes that AstraZeneca’s diabetes franchise faces stiff competition while pricing pressure is hurting sales in the respiratory unit.,0.021539822220802307,0.9642565846443176,0.014203638769686222,negative,-0.9427167773246765
24,2020-10-21 10:30:01,"Nonetheless, AstraZeneca’s newer drugs, mainly cancer medicines, Lynparza, Tagrisso and Imfinzi, should keep driving revenues.",0.9284478425979614,0.018619468435645103,0.05293264985084534,positive,0.9098283648490906
25,2020-10-21 10:30:01,"Its pipeline is strong with an abundance of catalysts lined up including data on COVID-19 vaccine candidate, AZD1222.",0.8746460676193237,0.012425270862877369,0.11292862147092819,positive,0.862220823764801
26,2020-10-21 10:30:01,AstraZeneca has also engaged in external acquisitions and strategic collaborations to boost its pipeline while investing in geographic areas of high growth like China.,0.9407022595405579,0.014311256818473339,0.0449865348637104,positive,0.9263910055160522
27,2020-10-21 10:30:01,Cost-cutting efforts should drive earnings.,0.9162166118621826,0.018381081521511078,0.06540224701166153,positive,0.8978355526924133
28,2020-10-21 10:30:01,The company has a mixed record of earnings surprises in the recent quarters.,0.06374352425336838,0.8299262523651123,0.10633020102977753,negative,-0.7661827206611633
29,2020-10-21 10:30:01,Estimates movement has been mixed ahead of Q3 earnings release.,0.031819507479667664,0.8727654814720154,0.09541501849889755,negative,-0.8409459590911865
30,2020-10-21 10:30:01,Other noteworthy reports we are featuring today include JPMorgan Chase and Chevron.,0.030230717733502388,0.006452971138060093,0.9633163809776306,neutral,0.02377774566411972
31,2020-10-21 10:30:01,"These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running.",0.7972503900527954,0.05419308319687843,0.1485564261674881,positive,0.7430573105812073
32,2020-10-21 10:30:01,"Right now, investors in these companies have a shot at serious profits.",0.6138336062431335,0.025691727176308632,0.36047467589378357,positive,0.5881418585777283
33,2020-10-21 10:30:01,"For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.",0.7051386833190918,0.15884511172771454,0.13601621985435486,positive,0.5462935566902161
34,2020-10-21 10:30:01,Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies.,0.8781022429466248,0.027150526642799377,0.09474720805883408,positive,0.8509517312049866
35,2020-10-21 10:30:01,"This could be one of the biggest buying opportunities of this decade, especially for those who get in early.",0.5791212320327759,0.02173202484846115,0.39914676547050476,positive,0.5573891997337341
36,2020-10-21 10:30:01,"See the 5 high-tech stocks now>>

Past performance is no guarantee of future results.",0.20228326320648193,0.13440074026584625,0.663316011428833,neutral,0.06788252294063568
37,2020-10-21 10:30:01,Inherent in any investment is the potential for loss.,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
38,2020-10-21 10:30:01,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
39,2020-10-21 10:30:01,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
40,2020-10-21 10:30:01,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
41,2020-10-21 10:30:01,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
42,2020-10-21 10:30:01,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
43,2020-10-21 10:30:01,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
44,2020-10-21 10:30:01,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
45,2020-10-21 10:30:01,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
46,2020-10-21 10:30:01,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
47,2020-10-21 10:30:01,Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01078665629029274,0.015373211354017258,0.9738401174545288,neutral,-0.004586555063724518
48,2020-10-21 10:30:01,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
49,2020-10-21 10:30:01,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
50,2020-10-21 10:30:01,"Click to get this free report

 

JPMorgan Chase Co. (JPM) : Free Stock Analysis Report

 

NVIDIA Corporation (NVDA) : Free Stock Analysis Report

 

AstraZeneca PLC (AZN) : Free Stock Analysis Report

 

Chevron Corporation (CVX) : Free Stock Analysis Report

 

salesforce.com, inc. (CRM) : Free Stock Analysis Report

 

To read this article on Zacks.com click here.",0.01211871113628149,0.017554206773638725,0.9703271389007568,neutral,-0.005435495637357235
